Percutaneous ethanol injection therapy of adenomatous hyperplastic nodules in cirrhotic liver disease

Riccardo Lencioni, D. Caramella, C. Bartolozzi, S. Mazzeo, G. Di Coscio

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Adenomatous hyperplastic nodules (AHNs) in cirrhotic liver are considered a precancerous condition which may lead to hepatocellular carcinoma (HCC). In this study, we treated a total of 23 AHNs in 15 patients with percutaneous ethanol injection (PEI). The treatment included 6 to 8 PEIs, performed on an out-patient basis under sonographic guidance. A 22 G (0.7 mm) spinal needle was used. The total amount of alcohol delivered into each lesion was 8 to 25 ml (mean 14.9 ml). At the end of treatment, complete necrosis of the nodule was proved in all cases by multiple fine-needle biopsies and confirmed by CT and MR findings. During follow-up (9-41 months, mean 24 months) no recurrences were demonstrated. However, HCC occurred elsewhere in the liver of 4 patients and additional AHNs were detected in 2 patients. Thus, PEI proved able to cause complete ablation of AHNs, presumably preventing their malignant transformation. However, patients with AHN remain at high risk for developing HCC.

Original languageEnglish (US)
Pages (from-to)138-142
Number of pages5
JournalActa Radiologica
Volume35
Issue number2
StatePublished - Mar 1994
Externally publishedYes

Fingerprint

Liver
Needles
Liver Diseases
Ethanol
Hepatocellular Carcinoma
Polyetherimides
Injections
Biopsy
Ablation
Alcohols
Precancerous Conditions
Therapeutics
Fine Needle Biopsy
Necrosis
Outpatients
Recurrence

ASJC Scopus subject areas

  • Engineering(all)
  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Lencioni, R., Caramella, D., Bartolozzi, C., Mazzeo, S., & Di Coscio, G. (1994). Percutaneous ethanol injection therapy of adenomatous hyperplastic nodules in cirrhotic liver disease. Acta Radiologica, 35(2), 138-142.

Percutaneous ethanol injection therapy of adenomatous hyperplastic nodules in cirrhotic liver disease. / Lencioni, Riccardo; Caramella, D.; Bartolozzi, C.; Mazzeo, S.; Di Coscio, G.

In: Acta Radiologica, Vol. 35, No. 2, 03.1994, p. 138-142.

Research output: Contribution to journalArticle

Lencioni, R, Caramella, D, Bartolozzi, C, Mazzeo, S & Di Coscio, G 1994, 'Percutaneous ethanol injection therapy of adenomatous hyperplastic nodules in cirrhotic liver disease', Acta Radiologica, vol. 35, no. 2, pp. 138-142.
Lencioni R, Caramella D, Bartolozzi C, Mazzeo S, Di Coscio G. Percutaneous ethanol injection therapy of adenomatous hyperplastic nodules in cirrhotic liver disease. Acta Radiologica. 1994 Mar;35(2):138-142.
Lencioni, Riccardo ; Caramella, D. ; Bartolozzi, C. ; Mazzeo, S. ; Di Coscio, G. / Percutaneous ethanol injection therapy of adenomatous hyperplastic nodules in cirrhotic liver disease. In: Acta Radiologica. 1994 ; Vol. 35, No. 2. pp. 138-142.
@article{16752de990a44ad1a98e8260746be83a,
title = "Percutaneous ethanol injection therapy of adenomatous hyperplastic nodules in cirrhotic liver disease",
abstract = "Adenomatous hyperplastic nodules (AHNs) in cirrhotic liver are considered a precancerous condition which may lead to hepatocellular carcinoma (HCC). In this study, we treated a total of 23 AHNs in 15 patients with percutaneous ethanol injection (PEI). The treatment included 6 to 8 PEIs, performed on an out-patient basis under sonographic guidance. A 22 G (0.7 mm) spinal needle was used. The total amount of alcohol delivered into each lesion was 8 to 25 ml (mean 14.9 ml). At the end of treatment, complete necrosis of the nodule was proved in all cases by multiple fine-needle biopsies and confirmed by CT and MR findings. During follow-up (9-41 months, mean 24 months) no recurrences were demonstrated. However, HCC occurred elsewhere in the liver of 4 patients and additional AHNs were detected in 2 patients. Thus, PEI proved able to cause complete ablation of AHNs, presumably preventing their malignant transformation. However, patients with AHN remain at high risk for developing HCC.",
author = "Riccardo Lencioni and D. Caramella and C. Bartolozzi and S. Mazzeo and {Di Coscio}, G.",
year = "1994",
month = "3",
language = "English (US)",
volume = "35",
pages = "138--142",
journal = "Acta Radiologica",
issn = "0284-1851",
publisher = "SAGE Publications Ltd",
number = "2",

}

TY - JOUR

T1 - Percutaneous ethanol injection therapy of adenomatous hyperplastic nodules in cirrhotic liver disease

AU - Lencioni, Riccardo

AU - Caramella, D.

AU - Bartolozzi, C.

AU - Mazzeo, S.

AU - Di Coscio, G.

PY - 1994/3

Y1 - 1994/3

N2 - Adenomatous hyperplastic nodules (AHNs) in cirrhotic liver are considered a precancerous condition which may lead to hepatocellular carcinoma (HCC). In this study, we treated a total of 23 AHNs in 15 patients with percutaneous ethanol injection (PEI). The treatment included 6 to 8 PEIs, performed on an out-patient basis under sonographic guidance. A 22 G (0.7 mm) spinal needle was used. The total amount of alcohol delivered into each lesion was 8 to 25 ml (mean 14.9 ml). At the end of treatment, complete necrosis of the nodule was proved in all cases by multiple fine-needle biopsies and confirmed by CT and MR findings. During follow-up (9-41 months, mean 24 months) no recurrences were demonstrated. However, HCC occurred elsewhere in the liver of 4 patients and additional AHNs were detected in 2 patients. Thus, PEI proved able to cause complete ablation of AHNs, presumably preventing their malignant transformation. However, patients with AHN remain at high risk for developing HCC.

AB - Adenomatous hyperplastic nodules (AHNs) in cirrhotic liver are considered a precancerous condition which may lead to hepatocellular carcinoma (HCC). In this study, we treated a total of 23 AHNs in 15 patients with percutaneous ethanol injection (PEI). The treatment included 6 to 8 PEIs, performed on an out-patient basis under sonographic guidance. A 22 G (0.7 mm) spinal needle was used. The total amount of alcohol delivered into each lesion was 8 to 25 ml (mean 14.9 ml). At the end of treatment, complete necrosis of the nodule was proved in all cases by multiple fine-needle biopsies and confirmed by CT and MR findings. During follow-up (9-41 months, mean 24 months) no recurrences were demonstrated. However, HCC occurred elsewhere in the liver of 4 patients and additional AHNs were detected in 2 patients. Thus, PEI proved able to cause complete ablation of AHNs, presumably preventing their malignant transformation. However, patients with AHN remain at high risk for developing HCC.

UR - http://www.scopus.com/inward/record.url?scp=0028388947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028388947&partnerID=8YFLogxK

M3 - Article

C2 - 8172738

AN - SCOPUS:0028388947

VL - 35

SP - 138

EP - 142

JO - Acta Radiologica

JF - Acta Radiologica

SN - 0284-1851

IS - 2

ER -